An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue

Genes and Development

Volumn 18, Issue 16, 2004, Pages 1976-1980

  Jaeschke, Anja ^a   Czech, Michael P ^a   Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Diabetes; Insulin; IRS 1; JIP1; JNK; Obesity

Indexed keywords

ADAPTOR PROTEIN; BINDING PROTEIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN JIP1; SERINE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; INSULIN RESISTANCE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADIPOSE TISSUE; ANIMALS; DIET; ENZYME ACTIVATION; INSULIN RESISTANCE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NUCLEAR PROTEINS; TRANS-ACTIVATORS;

ANIMALIA;

EID: 4043073652     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1216504     Document Type: Article

References (25)

1. Aguirre, V., Uchida, T., Yenush, L., Davis, R., and White, M.F. 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275: 9047-9054.
2. Aguirre, V., Werner, E.D., Giraud, J., Lee, Y.H., Shoelson, S.E., and White, M.F. 2002. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem. 277: 1531-1537.
3. Bennett, B.L., Satoh, Y., and Lewis, A.J. 2003. JNK: A new therapeutic target for diabetes. Curr. Opin. Pharmacol. 3: 420-425.
4. Berg, A.H., Combs, T.P., Du, X., Bzownlee, M., and Scherer, P.E. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7: 947-953.
5. Boden, G. 1997. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46: 3-10.
6. Bonny, C., Nicod, P., and Waeber, G. 1998. IB1, a JIP-1-related nuclear protein present in insulin-secreting cells. J. Biol. Chem. 273: 1843-1846.
7. Dickens, M., Rogers, J.S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J.R., Greenberg, M.E., Sawyers, C.L., and Davis, R.J. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277: 693-696.
8. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C.Z., Uysal, K.T., Maeda, K., Karin, M., and Hotamisligil, G.S. 2002. A central role for JNK in obesity and insulin resistance. Nature 420: 333-336.
9. Im, J.Y., Lee, K.W., Kim, M.H., Lee, S.H., Ha, H.Y., Cho, I.H., Kim, D., Yu, M.S., Kim, J.B., Lee, J.K., et al. 2003. Repression of phospho-JNK and infarct volume in ischemic brain of JIP1-deficient mice. J. Neurosci. Res. 74: 326-332.
10. Lee, Y.H., Giraud, J., Davis, R.J., and White, M.F. 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278: 2896-2902.
11. Manning, A.M. and Davis, R.J. 2003. Targeting JNK for therapeutic benefit: From junk to gold? Nat. Rev. Drug Discov. 2: 554-565.
12. Matsuzawa, Y., Funahashi, T., and Nakamura, T. 1999. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokines adipocyte-derived bioactive substances. Ann. NY Acad. Sci. 892: 146-154.
13. Matsuzawa, Y., Funahashi, T., Kihara, S., and Shimomura, I. 2003. Adiponectin and Metabolic Syndrome. Arterioscler. Thromb. Vasc. Biol. 24: 29-33.
14. Mauvais-Jarvis, F., Kulkarni, R.N., and Kahn, C.R. 2002. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin. Endocrinol. (Oxf.) 57: 1-9.
15. Michael, M.D., Kulkarni, R.N., Postic, C., Previs, S.F., Shulman, G.I., Magnuson, M.A., and Kahn, C.R. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 6: 87-97.
16. Mokdad, A.H., Bowman, B.A., Ford, E.S., Vinicor, F., Marks, J.S., and Koplan, J.P. 2001. The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 1195-1200.
17. Morrison, D.K. and Davis, R.J. 2003. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19: 91-118.
18. Thompson, N.A., Haefliger, J.A., Senn, A., Tawadros, T., Magara, F., Ledermann, B., Nicod, P., and Waeber, G. 2001. Islet-brain1/JNK-interacting protein-1 is required for early embryogenesis in mice. J. Biol. Chem. 276: 27745-27748.
19. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., and Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389: 610-614.
20. Waeber, G., Delplanque, J., Bonny, C., Mooser, V., Steinmann, M., Widmann, C., Maillard, A., Miklossy, J., Dina, C., Hani, E.H., et al. 2000. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat. Genet. 24: 291-295.
21. Whitmarsh, A.J. and Davis, R.J. 2001. Analyzing JNK and p38 mitogen-activated protein kinase activity. Methods Enzymol. 332: 319-336.
22. Whitmarsh, A.J., Cavanagh, J., Tournier, C., Yasuda, J., and Davis, R.J. 1998. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671-1674.
23. Whitmarsh, A.J., Kuan, C.Y., Kennedy, N.J., Kelkar, N., Haydar, T.F., Mordes, J.P., Appel, M., Rossini, A.A., Jones, S.N., Flavell, R.A., et al. 2001. Requirement of the JIP1 scaffold protein for stress-induced JNK activation. Genes & Dev. 15: 2421-2432.
24. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7: 941-946.
25. Yasuda, J., Whitmarsh, A.J., Cavanagh, J., Sharma, M., and Davis, R.J. 1999. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell Biol. 19: 7245-7254.